We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$417M
AUM Growth
-$24.5M
Cap. Flow
-$15.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$7.46M
2
LIN icon
Linde
LIN
+$6.13M
3
LOGI icon
Logitech
LOGI
+$3.75M
4
KO icon
Coca-Cola
KO
+$1.49M
5
AMZN icon
Amazon
AMZN
+$990K

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$14.3M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$7.54M
3
ALC icon
Alcon
ALC
+$5.41M
4
RACE icon
Ferrari
RACE
+$5.16M
5
CNH
CNH Industrial
CNH
+$2.87M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 15.28%
3 Consumer Discretionary 11.12%
4 Healthcare 10.96%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSIC icon
226
Henry Schein
HSIC
$9.78B
$401K 0.1%
+5,261
New +$405K
TGT icon
227
Target
TGT
$63.5B
$397K 0.1%
1,737
+26
+2% +$6.51K
ACTDU
228
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$397K 0.1%
40,000
KLAC icon
229
KLA
KLAC
$262B
$396K 0.1%
11,850
-160
-1% -$5.34K
ABBV icon
230
AbbVie
ABBV
$461B
$396K 0.1%
3,671
+35
+1% +$4K
NFLX icon
231
Netflix
NFLX
$293B
$395K 0.1%
6,480
-3,960
-38% -$218K
DOG
232
ProShares Short Dow30
DOG
$110M
$395K 0.09%
+11,500
New +$385K
CLOU icon
233
Global X Cloud Computing ETF
CLOU
$225M
$391K 0.09%
13,340
ARW icon
234
Arrow Electronics
ARW
$10.6B
$389K 0.09%
3,462
+3,423
+8,777% +$396K
AYX
235
DELISTED
Alteryx Inc
AYX
$388K 0.09%
5,305
-777
-13% -$58.5K
STE icon
236
Steris
STE
$21.3B
$388K 0.09%
1,898
+1,874
+7,808% +$401K
TWST icon
237
Twist Bioscience
TWST
$5.57B
$388K 0.09%
3,623
WY icon
238
Weyerhaeuser
WY
$17.4B
$387K 0.09%
10,884
+9,227
+557% +$323K
DBX icon
239
Dropbox
DBX
$7.02B
$369K 0.09%
12,643
+12,302
+3,608% +$382K
WMB icon
240
Williams Companies
WMB
$87.5B
$369K 0.09%
14,241
+2,739
+24% +$69K
LI icon
241
Li Auto
LI
$13B
$366K 0.09%
13,931
-72
-0.5% -$2.17K
CHRW icon
242
C.H. Robinson
CHRW
$20.9B
$366K 0.09%
4,206
-375
-8% -$33.9K
CIBR icon
243
First Trust NASDAQ Cybersecurity ETF
CIBR
$14B
$365K 0.09%
7,500
KMI icon
244
Kinder Morgan
KMI
$71.2B
$365K 0.09%
21,811
+4,834
+28% +$82.1K
AMBA icon
245
Ambarella
AMBA
$2.83B
$364K 0.09%
2,335
-440
-16% -$50.6K
UNP icon
246
Union Pacific
UNP
$180B
$361K 0.09%
1,841
-1,335
-42% -$288K
EQIX icon
247
Equinix
EQIX
$104B
$359K 0.09%
455
+96
+27% +$79.7K
AGCO icon
248
AGCO
AGCO
$8.71B
$359K 0.09%
+2,929
New +$383K
AOS icon
249
A.O. Smith
AOS
$8.58B
$357K 0.09%
5,844
+840
+17% +$58.7K
LEU icon
250
Centrus Energy
LEU
$3.4B
$354K 0.09%
9,164
+217
+2% +$6.02K

Similar funds

Exane Derivatives's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.

  • Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
  • Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
  • Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
  • Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
  • Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
  • Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
  • Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.